Medicine shortages and defects notification centre

The Medicine Shortages and Defects Notification Centre enables marketing authorisation holders to submit various notifications:

• Initial placing on the market of a medicinal product
• Discontinuation or interruption of the marketing of a medicinal product 
• A notification indicating that a medicinal product is being placed on the market in smaller quantities or to an insufficient extent
• A quality defect in relation to a medicinal product
• An out-of-specification of an advanced therapeutic medicinal product (ATMP)

Manufacturers, including compounding and collegiate dispensing pharmacies, can also submit notifications of a quality defect or an out-of-specification of an ATMP.

To do this, you can use the notification form. The user guide and the frequently asked questions page contain more details on the reporting procedures.